Watchlist for 7-16-2015 – $OHRP, $NVGN

Today’s Plan:

Small gains, but traded OK considering the circumstances. Glad I waited on $OHRP. Slow day on the scans, 8AM right now, ideally some action perks up in pre market, else this may be a non trading day 🙁 .

Today’s List: Full list from Yahoo Finance

Ohr Pharmaceutical, Inc. (OHRP) -NasdaqCM

Main watch today, but fading pre market, I wont’ short it here ($4.00) but hoping it collects a bunch more shorts and squeezes. But it probably fails. Dang…

Target: $4.50-$5.00

OHRP

Novogen Limited (NVGN) -NasdaqCM

Running in pre, but waiting for a big spike.

Target: True Para action.

NVGN

Watchlist for 3-4-2015 – $ATOS, $OREX, $NVGN, $EYES, $BIOC, $ONCY, $CYTX

Today’s Plan:

Another very solid day yesterday though my impatience killed me on both trades. Well actually just on one side of the trades, my entries were patient and kicked ass! Which has forever been one of my biggest issues, (not waiting for the best entry) but my exits were very poor. Could have DESTROYED $OREX had I held just a little longer.

Same plan for today, trade my list, and wait for my entries.

Today’s List: Full list from Yahoo Finance

ATOS

Watch List 2/21/2013 – $NVGN

I’m to stupid to have any idea what these guys do:

“Novogen Limited, a biotechnology company, engages in the research and development of prescription drugs. Its products include ME-143, an analogue of Phenoxodiol that is Phase I clinical trials; NV-128, a novel mitochondrial inhibitor, which is in preclinical trials targeting a range of cancers; ME-344, which is in Phase I clinical trials for the treatment of tumors; and GLYC-101 Gel to stimulate and modulate the natural cascade of wound healing activities in several cell populations. The company’s products also comprise NV-143, an active against melanoma cells; NV-04 to treat cardiovascular diseases; NV-27, an oral agent to prevent arterial restenosis; NV-07α for the protection of mice against UV-induced inflammatory changes in the skin, and against UV-induced skin immune suppression; flavonoid anti-inflammatory molecules for general pain relief; and NV-52, a synthetic anti-inflammatory drug. It operates primarily in Australia, North America, Europe, and Asia. The company was founded in 1992 and is headquartered in North Ryde, Australia.”

I do know this though, from the looks of google maps their “headquarters” is in a shared space with a construction remodeling company… That and the chart are enough for a bush league short seller like myself to itch to get a piece.

Full list from Yahoo Finance

NVGN

$NVGN